Shares of Utah Medical Products, Inc. (UTMD) have declined 4.1% since the company reported its earnings for the quarter ended Sept. 30, 2025. This compares to the S&P 500 index’s 2.8% growth over the same time frame. Over the past month, the stock has declined 7.1% compared with the S&P 500’s 3.1% growth.For the third quarter of 2025, Utah Medical reported an earnings per share (EPS) of 82 cents, which declined 19.9% from $1.025 in the prior-year quarter. The company witnessed a 1.9$ ...